Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Determination of the ability to drive and operate machines after single and multiple oral dose of Neramexane as compared to placebo
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| D | Placebo Comparator | healthy volunteers |
|
| C | Active Comparator | healthy volunteers |
|
| B | Active Comparator | healthy volunteers |
|
| A | Active Comparator | healthy volunteers |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Neramexane mesylate | Drug | tablets Group A: duration: 12,5 mg for 7 days and 25 mg for 8 days Group B: duration: 25 mg for 7 days and 50 mg for 8 days Group C: duration: 50 mg for 7 days and 75 mg for 8 days Group D: duration: placebo for 15 days |
| Measure | Description | Time Frame |
|---|---|---|
| Fitness to drive | 15 days |
| Measure | Description | Time Frame |
|---|---|---|
| Psychometric test and motor control tests | 15 days |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Merz Pharmaceuticals | Frankfurt am Main | 60318 | Germany |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided